LMG Life Sciences Awards EMEA 2023: key dates revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

LMG Life Sciences Awards EMEA 2023: key dates revealed

LMG-LS-2023-EMEA-logo-article

Key dates for the LMG Life Sciences research for 2023 have been released

The LMG Life Sciences Awards EMEA is excited to announce its return and reveal its key dates for 2023. The Awards, the preeminent industry event for legal work in the life sciences sector, will be open for submissions from December 8.

Please mark the following dates in your calendars:

LMG LS EMEA Dates.PNG

The life sciences industry will be invited to submit nominations for leading practitioners, firms, cases, and deals. The Awards will recognise the most outstanding work completed by private practice firms, as well as in-house legal teams and counsels during 2022.

If you have any questions about the research, please contact the LMG Life Sciences awards editor John Harrison.

 

LMG Life Sciences

LMG Life Sciences produces the most respected awards programme for life sciences practitioners and law firms across Europe, the Middle East, and Africa. Honourees are determined through a rigorous research process that aims to recognise and celebrate excellent legal work and client service over a 12-month period.

The awards span four broad practice areas: regulatory, intellectual property, financial & corporate, and non-IP litigation & enforcement.

In addition to award categories for firms and individuals, an array of unique awards are announced each year to highlight the achievements of in-house teams and to celebrate Impact Cases and Deals of the Year.

LMG Life Sciences is a sister publication to Managing IP and IP Stars.

more from across site and SHARED ros bottom lb

More from across our site

The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions
Ana Castedo, who brings a strong focus on patent litigation, will help build the firm’s IP litigation offering in Madrid
A former scientist, inventor and now a patent practice leader, Hanane Fathi Roswall shares her views on leadership, diversity, the rise of AI and the promise of the UPC
With rumours that a third IP judge could yet join the England and Wales High Court, we run through some potential names while practitioners outline the importance of a well-stocked bench
Gift this article